| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Johnson KL | |
| Poland GA | |||
| Ovsyannikova IG | |||
| Bergen HR 3rd | |||
| P2860 | cites work | Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response | Q28238379 |
| Automated protein identification by tandem mass spectrometry: issues and strategies | Q28281533 | ||
| SYFPEITHI: database for MHC ligands and peptide motifs | Q29616214 | ||
| Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines | Q30305718 | ||
| Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad | Q30311282 | ||
| Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members | Q30434514 | ||
| Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry | Q30434686 | ||
| Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy | Q30441689 | ||
| The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes | Q30444065 | ||
| Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses | Q30449492 | ||
| Identification by mass spectrometry of CD8(+)-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene product | Q30453239 | ||
| The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition | Q30470188 | ||
| The role of mass spectrometry in vaccine development | Q30659439 | ||
| HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles | Q30883609 | ||
| Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus | Q31007306 | ||
| Integrating epitope data into the emerging web of biomedical knowledge resources | Q31111568 | ||
| Use of double-depleted 13C and 15N culture media for analysis of whole cell bacteria by MALDI time-of-flight and Fourier transform mass spectrometry | Q33194529 | ||
| Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines | Q33210436 | ||
| HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation | Q34048199 | ||
| Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans | Q34195888 | ||
| Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype. | Q34464602 | ||
| Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. | Q34467405 | ||
| A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus | Q34536936 | ||
| Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides | Q34554618 | ||
| Lipopeptide vaccines--yesterday, today, and tomorrow | Q34749774 | ||
| Epitope-based vaccines: an update on epitope identification, vaccine design and delivery | Q35192612 | ||
| Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood. | Q35731386 | ||
| Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides | Q35754384 | ||
| Peptide-based therapeutic vaccines for allergic and autoimmune diseases | Q36090197 | ||
| Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition | Q36231571 | ||
| Counting individual sulfur atoms in a protein by ultrahigh-resolution Fourier transform ion cyclotron resonance mass spectrometry: experimental resolution of isotopic fine structure in proteins | Q36312552 | ||
| Identical peptides recognized by MHC class I- and II-restricted T cells | Q36356596 | ||
| Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 | Q36363763 | ||
| Peptide vaccines against cancer, infectious diseases, and conception | Q36664700 | ||
| Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes | Q37350720 | ||
| Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7. | Q40257224 | ||
| Disruption of MHC class II-restricted antigen presentation by vaccinia virus. | Q40354288 | ||
| Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination | Q40513340 | ||
| Naturally processed measles virus peptide eluted from class II HLA-DRB1*03 recognized by T lymphocytes from human blood | Q40568321 | ||
| Identification of an association between HLA class II alleles and low antibody levels after measles immunization | Q40680106 | ||
| Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis | Q40840571 | ||
| A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains | Q40887667 | ||
| Processing of DR1-restricted determinants from the fusion protein of measles virus following two distinct pathways | Q41222562 | ||
| Demonstration of virus-specific CD8+ memory T cells in measles-seropositive individuals by in vitro peptide stimulation | Q41291868 | ||
| Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays | Q41450491 | ||
| Effect of measles virus infection on MHC class II expression and antigen presentation in human monocytes | Q41564983 | ||
| Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis | Q41675478 | ||
| The minimal number of class II MHC-antigen complexes needed for T cell activation | Q41724410 | ||
| Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation | Q41725217 | ||
| Peptides recognized by class I restricted T cells also bind to MHC class II molecules | Q41755753 | ||
| Efficient MHC class II-restricted presentation of measles virus to T cells relies on its targeting to its cellular receptor human CD46 and involves an endosomal pathway | Q41935449 | ||
| Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers | Q42653193 | ||
| Influence of HLA-DRB1 alleles on lymphoproliferative responses to a naturally processed and presented measles virus phosphoprotein in measles immunized individuals | Q42850418 | ||
| A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway | Q43714208 | ||
| Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection | Q43882094 | ||
| Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes | Q44144189 | ||
| Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling. | Q44284826 | ||
| Dynamics of measles virus protein expression are reflected in the MHC class I epitope display | Q44534554 | ||
| Improved mass analysis of oligoribonucleotides by 13C, 15N double depletion and electrospray ionization FT-ICR mass spectrometry | Q44797985 | ||
| Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. | Q45284162 | ||
| Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination | Q45404238 | ||
| Identification of class II HLA-DRB1*03-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry | Q45421850 | ||
| Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein | Q45770087 | ||
| Recognition of intracellular measles virus antigens by HLA class II restricted measles virus-specific cytotoxic T lymphocytes | Q45839675 | ||
| Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. | Q48559352 | ||
| Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. | Q51583278 | ||
| Mass tag-assisted identification of naturally processed HLA class II-presented meningococcal peptides recognized by CD4+ T lymphocytes. | Q51992678 | ||
| In-gel isoelectric focusing of peptides as a tool for improved protein identification. | Q52669876 | ||
| Optimized peptide separation and identification for mass spectrometry based proteomics via free-flow electrophoresis. | Q52671958 | ||
| A comparison of immobilized pH gradient isoelectric focusing and strong-cation-exchange chromatography as a first dimension in shotgun proteomics. | Q53627527 | ||
| Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules | Q55042699 | ||
| New tools, new approaches and new ideas for vaccine development | Q57537644 | ||
| Probing Proteomes Using Capillary Isoelectric Focusing-Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry | Q58069292 | ||
| A new liquid chromatography/tandem mass spectrometric approach for the identification of class I major histocompatibility complex associated peptides that eliminates the need for bioassays | Q58842573 | ||
| Electron capture dissociation for structural characterization of multiply charged protein cations | Q73493699 | ||
| The application of proteomics in defining the T cell antigens of Mycobacterium tuberculosis | Q77075718 | ||
| Immunodominance in TCD8+ responses to viruses: cell biology, cellular immunology, and mathematical models | Q80444901 | ||
| Identification of protective and non-protective T cell epitopes in influenza | Q81157688 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 644-652 | |
| P577 | publication date | 2007-10-31 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Mass spectrometry and peptide-based vaccine development | |
| P478 | volume | 82 |
| Q36604367 | Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry |
| Q37293663 | Application of pharmacogenomics to vaccines |
| Q35785581 | Consistency of HLA associations between two independent measles vaccine cohorts: a replication study |
| Q97519043 | Current Challenges in Vaccinology |
| Q40885928 | Deciphering the human antigenome |
| Q37456000 | Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development |
| Q37674253 | Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD). |
| Q30358614 | Modular Three-component Delivery System Facilitates HLA Class I Antigen Presentation and CD8(+) T-cell Activation Against Tumors. |
| Q57157844 | Personalized vaccines: the emerging field of vaccinomics |
| Q36778316 | Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity |
| Q37393765 | Smallpox vaccines for biodefense |
| Q34364276 | Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. |
| Q35086204 | Systems biology approaches to new vaccine development |
| Q33813977 | The personal touch: strategies toward personalized vaccines and predicting immune responses to them |
| Q37039235 | Vaccine immunogenetics: bedside to bench to population |
| Q36836183 | Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor |
| Q35193959 | Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections |
| Q34126261 | Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery? |
| Q37119456 | Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century |
| Q51772775 | Vaccinomics, predictive vaccinology and the future of vaccine development. |
Search more.